Become A Featured Company

Experts Weigh in on Industry Opportunities and What’s Ahead at #CanndoraConnect: Women in Psychedelics

Ryan Allway

December 9th, 2020

Psychedelics, Top News

Canndora, a global media and event platform, and initiative created by Marigold Marketing & PR to support advancing women in emerging industries, hosted #CanndoraConnect: Women in Psychedelics on December 2nd, 2020. The event featured eight industry professionals and sold out with over 100 registrants from around the world.

#CanndoraConnect featured notable panellists and key partners who shared their expertise on critical topics, including opportunities for international business in psychedelics and the science behind psilocybin and its role in women’s health.

The event was made possible with support from presenting partners, Red Light Holland (CSE: TRIP | OTC: TRUFF | FSE: 4YX) and WAKE. 

“#CanndoraConnect: Women in Psychedelics was a truly insightful event and the panelists were incredibly knowledgeable. Having the opportunity to drive our business goals and network with other women is incredibly valuable, especially during a pandemic. The Wake team is proud to have been a presenting partner.”- Nichole Creary, VP Marketing, Wake.

 

#CanndoraConnect Panel Highlights

 

International Business

A global revolution is underway and the psychedelics market is full of opportunities for Canadian companies operating on a national and international level. The panellists discussed working on international teams in Canada, Jamaica and Netherlands and the differences between each region’s industries.

 

In a pre-event interview with Truffle Report, Ann Barnes, Director of Red Light Holland expressed that she thinks decriminalization of psychedelics in Canada will be here sooner rather than later. “Decriminalization is a significant area of what I hope to be a part of. It’s shameful these incredible gifts from nature have been excluded from our medicinal opportunities because of political stigma and ignorance. It should be done tomorrow because we need it today.”

 

Psilocybin and Women: What does Science Say?

Due to psychedelics being extremely regulated over the past several decades research has been minimal until recently. A small body of research means gender differences have largely been left out of psychedelics studies. As we know, male and female bodies are drastically different and the lack of research and awareness of those key differentiators can cause major systemic issues in how society addresses women’s health such as more women dying of heart attacks and ADHD being underdiagnosed in girls. The panellists expressed they are hopeful the psychedelic industry will delve into gender specific research as the industry continues to develop, especially since women are playing such a large part in its creation. 

 

In a pre-event interview with Truffle Report, Susan Chapelle, President of Havn Labs shared her belief that the integration of psychedelics into women’s health will be an exploding industry. “It’s crazy, women experience so much trauma, for example depression from infertility or losing a child. There are so many conditions, some are gendered and some are not. Still, overwhelmingly women are the majority experiencing these things,” she says. “In all these companies there is still a dearth of women. I saw the cannabis space in a positive light for a while with women entering leadership positions but as we see the market expanding in Canada that has been really restricted. I am hoping that companies see the value in having a diversity of opinion and equity across the psychedelics space.”

 

#CanndoraConnect Speakers included: 

  • Ann Barnes, Director of Red Light Holland
  • Sarah Hashkes, CEO of Radix Motion
  • Terri Smith, Chief Mycologist of WAKE
  • Dr. Olga Chernoloz, Chief Scientific Officer of WAKE
  • Susan Chapelle, President of Havn Labs
  • Irie Selkirk, Co-founder & Director of Rise Wellness Retreats
  • Salimeh Tabrizi, Co-Founder Canadian Psychedelic Association
  • Sabrina Ramkellawan: COO & Co-Founder Knowde Group Inc. & President Clinical Research Association of Canada

 

You can catch up on these insightful conversations and watch both of the panels on the Canndora website now.

Canndora and Marigold PR will be hosting more events for women in the Psychedelic and Cannabis Industries. Sign up now for WWC Conference, taking place virtually May 26th, 2021

Media Contact:
Danielle McKay, Marketing and Media Executive
Marigold PR

danielle@marigoldpr.com
905-808-7230.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading